Protein signatures for survival and recurrence in metastatic melanoma
نویسندگان
چکیده
منابع مشابه
Survival and Recurrence in Non-melanoma Skin Cancers of scalp
Abstract Introduction: Non-melanoma scalp skin cancers (NMSCs) including squamous cell carcinomas (SCCs) and basal cell carcinomas (BCCs) are common. To manage such cancers, especially SCCs, more attention should be paid to their invasive characteristics. Mortality surveillance of SCCs and BCCs of scalp helps to choose proper approaches. Methods: The current retrospective, descriptive study w...
متن کاملSurvival and Recurrence in Non-melanoma Skin Cancers of scalp
Abstract Introduction: Non-melanoma scalp skin cancers (NMSCs) including squamous cell carcinomas (SCCs) and basal cell carcinomas (BCCs) are common. To manage such cancers, especially SCCs, more attention should be paid to their invasive characteristics. Mortality surveillance of SCCs and BCCs of scalp helps to choose proper approaches. Methods: The current retrospective, descriptive study w...
متن کاملCirculating melanoma cells and survival in metastatic melanoma.
A validated assay for the enumeration of circulating melanoma cells (CMCs) may facilitate the development of more effective therapies for metastatic melanoma patients. In this study CD146+ cells were immunomagnetically enriched from 7.5 ml of blood. Isolated cells were fluorescently stained with DAPI, anti-molecular weight melanoma-associated antigen (HMW-MAA), anti-CD45 and CD34 and Ki67. CMCs...
متن کاملPort site recurrence after laparoscopic adrenalectomy for metastatic melanoma.
Port site metastasis after adrenal surgery is a rare entity. We describe the case of a 70-year-old man with a solitary adrenal metastasis from malignant melanoma, which was laparoscopically removed. Twelve months later, he presented a recurrence near one of the laparoscopic port sites. This lesion was surgically removed and after a 18-month follow-up, the patient presents no evidence of disease.
متن کاملMelanoma MicroRNA signature predicts post-recurrence survival.
PURPOSE To identify a melanoma microRNA (miRNA) expression signature that is predictive of outcome and then evaluate its potential to improve risk stratification when added to the standard-of-care staging criteria. EXPERIMENTAL DESIGN Total RNA was extracted from 59 formalin-fixed paraffin-embedded melanoma metastases and hybridized to miRNA arrays containing 911 probes. We then correlated mi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Proteomics
سال: 2011
ISSN: 1874-3919
DOI: 10.1016/j.jprot.2011.04.013